NEW YORK (Reuters Health) – Patients with type 2 diabetes who also have liver cirrhosis associated with hepatitis C virus (HCV) infection fare significantly better when they’re treated with metformin, results of a French study indicate. “We found that metformin treatment was independently associated with a decrease in HCC (hepatocellular carcinoma) occurrence and with a … Continue reading Metformin improves outcomes in diabetics with hepatitis C cirrhosis